Join the Fun: Theriva Biologics’ Conference Call and Webcast for a Quirky Discussion on Q3 2022 Operational Highlights and Financial Results!
Welcome to the Theriva Biologics Conference Call! Get ready to dive deep into the world of cancer therapeutics Rockville, Md., Nov. 03, 2022 (GLOBE NEWSWIRE) — Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, is…